5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionArterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hyperlipidemia, metabolic disease, myocardial ischemia, vascular disorderRecruitingPhase 42026-10-05NCT06909565
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsInsulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, prediabetes syndrome, type 2 diabetes mellitusRecruitingNot applicable2026-09-28NCT06112418
NORM-HF Pivotal Studycardiovascular disorder, heart disorder, heart failureRecruitingNot applicable2026-08-25NCT07574593
Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapycardiovascular disorder, heart disorder, heart failureActive, not recruitingNot stated2025-11-20NCT03970343
RADIANCE Continued Access ProtocolHypertension Resistant to Conventional Therapy, cardiovascular disorder, essential hypertension, hypertensive disorder, vascular disorderActive, not recruitingNot applicable2024-06-17NCT05017935